Moustafa E. El‐Araby

533 total citations
35 papers, 410 citations indexed

About

Moustafa E. El‐Araby is a scholar working on Organic Chemistry, Molecular Biology and Genetics. According to data from OpenAlex, Moustafa E. El‐Araby has authored 35 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Organic Chemistry, 16 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Moustafa E. El‐Araby's work include Synthesis and biological activity (8 papers), Hemoglobinopathies and Related Disorders (7 papers) and Synthesis and Reactions of Organic Compounds (4 papers). Moustafa E. El‐Araby is often cited by papers focused on Synthesis and biological activity (8 papers), Hemoglobinopathies and Related Disorders (7 papers) and Synthesis and Reactions of Organic Compounds (4 papers). Moustafa E. El‐Araby collaborates with scholars based in Egypt, Saudi Arabia and United States. Moustafa E. El‐Araby's co-authors include Abdelsattar M. Omar, Khaled A. M. Abouzid, Mosaad S. Mohamed, Mohamed Elsayed, Michael Linscheid, Maan T. Khayat, Eman Ahmed, Ahmed H. El‐Khatib, Nadia A. Khalil and Rabah A.T. Serya and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Moustafa E. El‐Araby

33 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moustafa E. El‐Araby Egypt 12 238 142 42 35 30 35 410
Marina Kritsanida France 12 350 1.5× 231 1.6× 40 1.0× 12 0.3× 41 1.4× 26 654
Xiaoshan Xu China 9 357 1.5× 268 1.9× 60 1.4× 17 0.5× 29 1.0× 19 806
Yaser A. Mostafa Egypt 16 336 1.4× 265 1.9× 50 1.2× 8 0.2× 91 3.0× 41 618
Lucia Crosta Italy 9 201 0.8× 236 1.7× 40 1.0× 8 0.2× 65 2.2× 11 522
Arshia Arshia Pakistan 13 486 2.0× 245 1.7× 53 1.3× 6 0.2× 50 1.7× 31 686
Alicja Urbaniak United States 13 198 0.8× 131 0.9× 33 0.8× 5 0.1× 82 2.7× 30 443
Canhui Zheng China 14 257 1.1× 227 1.6× 57 1.4× 9 0.3× 47 1.6× 37 446
Nian‐Guang Li China 13 140 0.6× 151 1.1× 90 2.1× 11 0.3× 29 1.0× 28 408
Ghulam Nabi Bader India 11 47 0.2× 117 0.8× 27 0.6× 27 0.8× 20 0.7× 38 387
Supriyo Saha India 13 141 0.6× 155 1.1× 35 0.8× 5 0.1× 30 1.0× 52 378

Countries citing papers authored by Moustafa E. El‐Araby

Since Specialization
Citations

This map shows the geographic impact of Moustafa E. El‐Araby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moustafa E. El‐Araby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moustafa E. El‐Araby more than expected).

Fields of papers citing papers by Moustafa E. El‐Araby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moustafa E. El‐Araby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moustafa E. El‐Araby. The network helps show where Moustafa E. El‐Araby may publish in the future.

Co-authorship network of co-authors of Moustafa E. El‐Araby

This figure shows the co-authorship network connecting the top 25 collaborators of Moustafa E. El‐Araby. A scholar is included among the top collaborators of Moustafa E. El‐Araby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moustafa E. El‐Araby. Moustafa E. El‐Araby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rehan, Mohd, Firoz Ahmed, Mohammad Imran Khan, et al.. (2024). Computational insights into the stereo-selectivity of catechins for the inhibition of the cancer therapeutic target EGFR kinase. Frontiers in Pharmacology. 14. 1231671–1231671. 4 indexed citations
2.
Alasmary, Fatmah Ali, Vijay H. Masand, Abir Ben Bacha, et al.. (2024). Synthesis, molecular modelling, and biological evaluation of novel quinoxaline derivatives for treating type II diabetes. Journal of Enzyme Inhibition and Medicinal Chemistry. 39(1). 2395985–2395985. 1 indexed citations
3.
Mohamed, Gamal A., et al.. (2023). Assessments of Alpha-Amylase Inhibitory Potential of Tagetes Flavonoids through In Vitro, Molecular Docking, and Molecular Dynamics Simulation Studies. International Journal of Molecular Sciences. 24(12). 10195–10195. 9 indexed citations
4.
Khayat, Maan T., Abdelsattar M. Omar, Farid Ahmed, et al.. (2022). Insights on Cancer Cell Inhibition, Subcellular Activities, and Kinase Profile of Phenylacetamides Pending 1H-Imidazol-5-One Variants. Frontiers in Pharmacology. 12. 794325–794325. 2 indexed citations
5.
Farag, Mohamed A., et al.. (2022). An updated multifaceted overview of sweet proteins and dipeptides as sugar substitutes; the chemistry, health benefits, gut interactions, and safety. Food Research International. 162(Pt A). 111853–111853. 29 indexed citations
6.
Omar, Abdelsattar M., Maan T. Khayat, Farid Ahmed, et al.. (2022). SAR Probing of KX2-391 Provided Analogues With Juxtaposed Activity Profile Against Major Oncogenic Kinases. Frontiers in Oncology. 12. 879457–879457. 2 indexed citations
7.
8.
Omar, Abdelsattar M., Moustafa E. El‐Araby, Tamer M. Abdelghany, et al.. (2020). Introducing of potent cytotoxic novel 2-(aroylamino)cinnamamide derivatives against colon cancer mediated by dual apoptotic signal activation and oxidative stress. Bioorganic Chemistry. 101. 103953–103953. 4 indexed citations
9.
Omar, Abdelsattar M., Mahmoud A. Elfaky, Stefan T. Arold, et al.. (2020). 1H-Imidazole-2,5-Dicarboxamides as NS4A Peptidomimetics: Identification of a New Approach to Inhibit HCV-NS3 Protease. Biomolecules. 10(3). 479–479. 3 indexed citations
10.
El‐Araby, Moustafa E. & Abdelsattar M. Omar. (2020). A single‐step synthesis of 1,3,4, 6‐tetraaryl ‐5‐aryliminopiperazin‐2‐one. Journal of Heterocyclic Chemistry. 58(2). 442–449. 1 indexed citations
11.
12.
El‐Araby, Moustafa E., et al.. (2017). Molecular Mimics of Classic P-Glycoprotein Inhibitors as Multidrug Resistance Suppressors and Their Synergistic Effect on Paclitaxel. PLoS ONE. 12(1). e0168938–e0168938. 20 indexed citations
13.
Omar, Abdelsattar M., Mona A. Mahran, Mohini S. Ghatge, et al.. (2016). Aryloxyalkanoic Acids as Non-Covalent Modifiers of the Allosteric Properties of Hemoglobin. Molecules. 21(8). 1057–1057. 5 indexed citations
14.
Omar, Abdelsattar M., Mona A. Mahran, Mohini S. Ghatge, et al.. (2015). Identification of a novel class of covalent modifiers of hemoglobin as potential antisickling agents. Organic & Biomolecular Chemistry. 13(22). 6353–6370. 17 indexed citations
15.
Elsayed, Mohamed, Moustafa E. El‐Araby, Rabah A.T. Serya, et al.. (2012). Structure-based design and synthesis of novel pseudosaccharine derivatives as antiproliferative agents and kinase inhibitors. European Journal of Medicinal Chemistry. 61. 122–131. 41 indexed citations
16.
Mohamed, Mosaad S., et al.. (2012). Potent Anticonvulsant 1H-Imidazol-5(4H)-One Derivatives with Low Neurotoxicity. 2(2). 24–29. 4 indexed citations
17.
Elsayed, Mohamed, Moustafa E. El‐Araby, Rabah A.T. Serya, & Khaled A. M. Abouzid. (2012). Virtual Screening and Synthesis of New Chemical Scaffolds as VEGFR-2 Kinase Inhibitors. Arzneimittelforschung. 62(12). 554–560. 1 indexed citations
18.
El‐Araby, Moustafa E., et al.. (2012). Design, Synthesis and in Vivo Anti-inflammatory Activities of 2,4-Diaryl-5-4H-imidazolone Derivatives. Molecules. 17(10). 12262–12275. 45 indexed citations
19.
El‐Araby, Moustafa E., Ralph J. Bernacki, Gergely M. Makara, Paula Pera, & Wayne K. Anderson. (2004). Synthesis, molecular modeling, and evaluation of nonphenolic indole analogs of mycophenolic acid. Bioorganic & Medicinal Chemistry. 12(11). 2867–2879. 16 indexed citations
20.
El‐Araby, Moustafa E., Richard S. Pottorf, & Mark R. Player. (2004). Synthesis of a 2, 4, 8-Trisubstituted Pyrimidino[5, 4-d]Pyrimidine Library via Sequential SNAr Reactions on Solid-Phase. Combinatorial Chemistry & High Throughput Screening. 7(5). 413–421. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marina Kritsanida Breakdown of academic impact, for papers by Xiaoshan Xu Breakdown of academic impact, for papers by Yaser A. Mostafa Breakdown of academic impact, for papers by Lucia Crosta Breakdown of academic impact, for papers by Arshia Arshia Breakdown of academic impact, for papers by Alicja Urbaniak Breakdown of academic impact, for papers by Canhui Zheng Breakdown of academic impact, for papers by Nian‐Guang Li Breakdown of academic impact, for papers by Ghulam Nabi Bader Breakdown of academic impact, for papers by Supriyo Saha
Rankless by CCL
2026